These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7144313)

  • 1. [Estimation of portal pressure in cirrhotic patients by biochemical parameters: study of multiple correlations].
    González Reimers CE; Santolaria Fernández F; Jorge Hernández JA; Batista López N; de Armas Trujillo D; Hernández Nieto L
    Med Clin (Barc); 1982 Oct; 79(6):264-7. PubMed ID: 7144313
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical course and liver circulation following shunt operations in portal hypertension].
    Hoffmeister HE
    Med Klin; 1969 Dec; 64(50):2332-7. PubMed ID: 5381616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fluctuations of portal pressure under normal conditions and evaluation of the severity of portal hypertension in liver cirrhosis].
    Mansurov KhKh
    Ter Arkh; 1971 Jul; 43(6):65-9. PubMed ID: 5125988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
    Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
    [No Abstract]   [Full Text] [Related]  

  • 5. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Hypostin infusion on the pressure of hepatic vein occlusion in portal hypertension].
    Machill K; Seifert A; Zellerhoff W
    Z Gesamte Inn Med; 1972 Aug; 27(15):668-71. PubMed ID: 4641143
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
    Yin J; Leng X; Zhu J
    Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?
    Lim JK; Groszmann RJ
    Hepatology; 2007 May; 45(5):1087-90. PubMed ID: 17464984
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein thrombosis.
    Keiding S; Solvig J; Grønbaek H; Vilstrup H
    Scand J Gastroenterol; 2004 Jun; 39(6):594-9. PubMed ID: 15223686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term effects of propranolol on portal pressure in cirrhotic patients.
    Orban-Schiopu AM; Popescu CR
    Rom J Gastroenterol; 2003 Mar; 12(1):25-30. PubMed ID: 12673376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
    Feng H; Leng X; Zhang Z
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study.
    Nguyen GC; Correia AJ; Thuluvath PJ
    Dis Colon Rectum; 2009 Aug; 52(8):1367-74. PubMed ID: 19617746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Portal cavernoma in cirrhotic patients. Report of 6 cases (author's transl)].
    Barbare JC; Outters F; Cornud F; Grenier P; Nahum H
    Gastroenterol Clin Biol; 1981; 5(6-7):616-9. PubMed ID: 7250614
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-1 adrenergic receptors in liver plasma membranes of cirrhotic patients with portal hypertension: a quantitative study.
    Zhang Y; Leng X; Zhu J; Peng J; Du R
    Chin Med J (Engl); 1998 Jun; 111(6):507-9. PubMed ID: 11245068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of intrahepatic pressure as an index of portal pressure].
    Urdaneta AB; Morillo AV; Núnez AP; Albarrán HB
    G E N; 1973 Oct-1974 Jul; 28(2-4):111-8. PubMed ID: 4219194
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum levels of epinephrine and norepinephrine in cirrhotic patients with portal hypertension.
    Zhu J; Leng X; Zhao H; Chen L; Du R
    Chin Med J (Engl); 1998 Jun; 111(6):504-6. PubMed ID: 11245067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
    Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F
    J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.